QCG
KIDS icon

Quadrant Capital Group’s OrthoPediatrics KIDS Stock Holding History

Quadrant Capital Group’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,099
Closed -$17.4K – 1933
2026
Q1 		$17.4K Buy
1,099
+981
+831% +$17.1K ﹤0.01% 2042
2025
Q4 		$2.1K Buy
118
+93
+372% +$1.63K ﹤0.01% 2515
2025
Q3 		$464 Buy
+25
New +$515 ﹤0.01% 2624
2025
Q1 		– Sell
-103
Closed -$2.39K – 2805
2024
Q4 		$2.39K Sell
103
-525
-84% -$13.1K ﹤0.01% 2472
2024
Q3 		$17K Sell
628
-68
-10% -$2.06K ﹤0.01% 1968
2024
Q2 		$20K Sell
696
-30
-4% -$920 ﹤0.01% 1853
2024
Q1 		$21.2K Hold
726
– – ﹤0.01% 1826
2023
Q4 		$23.6K Buy
726
+694
+2,169% +$20.1K ﹤0.01% 1740
2023
Q3 		$1.02K Buy
+32
New +$1.23K ﹤0.01% 2485
2020
Q3 		– Sell
-999
Closed -$44K – 2240
2020
Q2 		$44K Buy
+999
New +$44.9K 0.01% 765

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Quadrant Capital Group's KIDS Position: Q2 2026 in Review

Quadrant Capital Group sold out of OrthoPediatrics (KIDS) in Q2 2026, closing a stake of 1,099 shares — an estimated $17.4K sold.

Quadrant Capital Group first reported a position in KIDS in Q2 2020 and held it in 10 quarters. The position peaked at $44K in Q2 2020. 120 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Quadrant Capital Group reported no remaining OrthoPediatrics position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 1,099 OrthoPediatrics shares in Q2 2026, an estimated $17.4K.
  • Quadrant Capital Group first reported a position in OrthoPediatrics in Q2 2020 and held it in 10 quarters.
  • Quadrant Capital Group's OrthoPediatrics position peaked at $44K in Q2 2020.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.